Search

West Pharmaceutical Services Inc

Ouvert

SecteurSoins de santé

397.1 1.86

Résumé

Variation du prix de l'action

24h

Actuel

Min

388.61

Max

397.28

Chiffres clés

By Trading Economics

Revenu

15M

154M

Ventes

27M

872M

P/E

Moyenne du Secteur

49.156

49.241

BPA

2.37

Rendement du dividende

0.23

Marge bénéficiaire

17.654

Employés

10,800

EBITDA

6.8M

225M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+5.74% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

0.23%

2.15%

Prochains Résultats

29 oct. 2026

Date du Prochain Dividende

18 nov. 2026

Date du Prochain Détachement de Dividende

11 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

2.1B

27B

Ouverture précédente

395.24

Clôture précédente

397.1

West Pharmaceutical Services Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 oct. 2026, 20:51 UTC

West Pharmaceutical Services Inc is experiencing a decline in after-market trading, now at its lowest point of the day.

23 oct. 2026, 19:36 UTC

West Pharmaceutical Services Inc shares fell modestly after earlier gains, remaining below Thursday's close but above the 20-day moving average.

22 oct. 2026, 21:02 UTC

West Pharmaceutical Services Inc shares fell in after-market trading, continuing a downward trend that began after Thursday's close.

21 oct. 2026, 22:16 UTC

West Pharmaceutical Services Inc shares have shown a slight decline in after-market hours, remaining flat since Wednesday's close and above its 20-day moving average.

20 oct. 2026, 23:06 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, having retraced earlier gains since Tuesday's close.

19 oct. 2026, 21:51 UTC

West Pharmaceutical Services Inc. is trading modestly higher in after-market hours, marking its highest cumulative return of the day after eight consecutive sessions of gains.

16 oct. 2026, 19:36 UTC

West Pharmaceutical Services Inc shares are lower, having declined from Thursday's close and experiencing a notable dip earlier in the session.

15 oct. 2026, 23:11 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, showing a modest increase since Thursday's close, continuing a streak of six consecutive higher sessions.

14 oct. 2026, 22:01 UTC

West Pharmaceutical Services Inc shares are trading modestly lower in after-market hours, retracing to a session low following four consecutive sessions of gains.

13 oct. 2026, 23:16 UTC

West Pharmaceutical Services Inc is trading modestly higher in after-market hours, continuing a trend of upward movement following four consecutive daily increases.

12 oct. 2026, 23:56 UTC

West Pharmaceutical Services Inc's shares advanced modestly during after-market hours, with a cumulative return peaking at 0.64% before settling around 0.36%.

9 oct. 2026, 22:01 UTC

West Pharmaceutical Services Inc is trading higher in after-market hours, showing a significant recovery from earlier losses since Friday's close.

8 oct. 2026, 20:07 UTC

West Pharmaceutical Services Inc shares are modestly lower, marking the fourth consecutive day of declines amid significant broader market downward pressure.

6 oct. 2026, 20:02 UTC

West Pharmaceutical Services Inc shares fell modestly, dipping below Monday's close after an early high but remaining above the 20-day moving average.

5 oct. 2026, 20:01 UTC

News

West Pharmaceutical Services Inc. is participating in CPHI Worldwide in Milan to showcase its drug packaging solutions, with shares trading higher amid recent gains.

2 oct. 2026, 22:01 UTC

Modestly higher in after-market, nearing one-month trading range high.

1 oct. 2026, 23:01 UTC

West Pharmaceutical Services Inc is trading modestly higher in after-market hours, remaining well above its 20-day moving average and near the upper end of its one-month trading range.

30 sept. 2026, 19:46 UTC

West Pharmaceutical Services Inc is trading lower, reaching its lowest point of the day, despite remaining above its 20-day moving average.

29 sept. 2026, 22:01 UTC

West Pharmaceutical Services Inc experienced a modest decline in after-market trading, retracing from earlier gains to its lowest point of the day.

28 sept. 2026, 20:07 UTC

West Pharmaceutical Services Inc is up in the current session, recovering from an early dip and settling above Friday's close while near its one-month trading range high.

25 sept. 2026, 20:07 UTC

West Pharmaceutical Services Inc shares fell modestly as the broader market declines, despite remaining above its 20-day moving average and near the upper end of its one-month range.

24 sept. 2026, 22:40 UTC

West Pharmaceutical Services Inc declined in after-hours trading, reversing an initial gain, despite remaining above its 20-day moving average.

23 sept. 2026, 23:51 UTC

West Pharmaceutical Services Inc is seeing a modest decline in after-market trading, positioned at the lower end of today's range but above its 20-day moving average.

22 sept. 2026, 20:02 UTC

News

Morgan Stanley upgraded West Pharmaceutical Services Inc to Overweight and raised its price target to $400, contributing to a significant rise in the stock.

18 sept. 2026, 20:03 UTC

West Pharmaceutical Services Inc shares fell sharply, reversing from an earlier peak to drop to their lowest point late in the morning amid a broader decline.

17 sept. 2026, 22:41 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, moving lower alongside the broader market's significant downward movement.

16 sept. 2026, 20:13 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, significantly above its 20-day moving average since Wednesday's close.

15 sept. 2026, 20:13 UTC

West Pharmaceutical Services shares are lower in after-market hours amid negative market sentiment and concerns over economic momentum and potential interest rate hikes.

14 sept. 2026, 20:07 UTC

News

West Pharmaceutical Services is gaining as CFO discusses strong second-quarter results at the Morgan Stanley conference, despite a recent cyber incident.

11 sept. 2026, 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

Comparaison

Variation de prix

West Pharmaceutical Services Inc prévision

Objectif de Prix

By TipRanks

5.74% hausse

Prévisions sur 12 Mois

Moyen 417.4 USD  5.74%

Haut 440 USD

Bas 400 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

5

Achat

0

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat